ETFinnovators (< 20)

AspenBio Pharma Poised for Active Year-End

October 16, 2008 – Comments (0) | RELATED TICKERS: APPY , HHD

AspenBio Pharma (APPY) should be close to completing patient enrollment in its 510(k) clinical trial for AppyScore based on its previous update in early September when the trial had reached the half-way point in patients. AppyScore is the world's first blood-based diagnostic tool for human appendicitis and APPY expects to file the 510(k0 before year-end with potential approval in early 2009